540975 Stoklara Genel Bakış Aster DM Healthcare Limited, bağlı ortaklıklarıyla birlikte Hindistan, Birleşik Arap Emirlikleri, Katar, Umman, Suudi Arabistan Krallığı, Ürdün, Kuveyt ve Bahreyn ile Mauritius Cumhuriyeti'nde sağlık ve yardımcı hizmetler sunmaktadır. Daha fazla detay
Ödüller Risk Analizi Tüm Risk Kontrollerini Gör Düşüncelerinizi, bağlantılarınızı ve şirket anlatımınızı yakalayın
Aster DM Healthcare Limited Rakipler Fiyat Geçmişi ve Performans
Hisse fiyatlarındaki yükseliş, düşüş ve değişimlerin özeti Aster DM Healthcare Tarihsel hisse senedi fiyatları Güncel Hisse Fiyatı ₹486.85 52 Haftanın En Yüksek Seviyesi ₹558.30 52 Haftanın En Düşük Seviyesi ₹312.25 Beta 0.62 1 Aylık Değişim 12.31% 3 Aylık Değişim 15.52% 1 Yıllık Değişim 23.00% 3 Yıllık Değişim 183.22% 5 Yıllık Değişim 214.00% Halka arzdan bu yana değişim 156.24%
Son Haberler & Güncellemeler
Price target increased by 12% to ₹551 Dec 03 Aster DM Healthcare Limited announced that it expects to receive funding from BCP Asia II Topco Iv PTE. Ltd., Centella Mauritius Holdings Limited Nov 30
Aster DM Healthcare Limited (NSEI:ASTERDM) entered into a Share Purchase Agreement to acquire 13% stake in Prerana Hospital Limited. Nov 27
Aster DM Healthcare and Quality Care India Merger Talks Reportedly Enters Final Lap Nov 11
Price target increased by 9.1% to ₹463 Oct 25
Second quarter 2025 earnings: EPS and revenues exceed analyst expectations Oct 24 Daha fazla güncelleme görün
Price target increased by 12% to ₹551 Dec 03 Aster DM Healthcare Limited announced that it expects to receive funding from BCP Asia II Topco Iv PTE. Ltd., Centella Mauritius Holdings Limited Nov 30
Aster DM Healthcare Limited (NSEI:ASTERDM) entered into a Share Purchase Agreement to acquire 13% stake in Prerana Hospital Limited. Nov 27
Aster DM Healthcare and Quality Care India Merger Talks Reportedly Enters Final Lap Nov 11
Price target increased by 9.1% to ₹463 Oct 25
Second quarter 2025 earnings: EPS and revenues exceed analyst expectations Oct 24
Aster DM Healthcare Limited to Report Q2, 2025 Results on Oct 23, 2024 Oct 17
Aster DM Healthcare Appoints Mohamed Alshamari as CEO of Aster Hospitals and Clinics in Saudi Arabia Oct 08 Aster DM Healthcare and Quality CARE Reportedly in Final Stages of Negotiations and Expects Deal to be Sign by the End of September 2024
Aster DM Healthcare Limited Announces Executive Changes Sep 11
High number of new directors Sep 10 Aster DM Healthcare Limited Approves Board Appointments
Upcoming dividend of ₹2.00 per share Aug 15
Blackstone Reportedly in Talks with the Promoters of Aster DM Healthcare to Merge Quality Care India with Aster Aug 06
First quarter 2025 earnings released: EPS: ₹1.49 (vs ₹0.10 in 1Q 2024) Aug 01
Aster DM Healthcare Limited to Report Q1, 2025 Results on Jul 31, 2024 Jul 25 Olympus Capital Asia Investments to Sell Up to 10% Stake in Aster DM Healthcare through Block Deals Jun 21
Aster DM Healthcare Limited, Annual General Meeting, Aug 29, 2024 May 31
New minor risk - Dividend sustainability May 31
Price target decreased by 7.3% to ₹453 May 30
Aster Dm Healthcare Limited Proposes Final Dividend for the Financial Year 2023-24 May 30
Aster Dm Healthcare Limited Proposes Final Dividend for the Financial Year 2023-24 May 29
Full year 2024 earnings released: EPS: ₹2.46 (vs ₹8.54 in FY 2023) May 29
Aster DM Healthcare Limited to Report Q4, 2024 Results on May 28, 2024 May 24 Aster DM Healthcare Limited Announces Resignation of Amitabh Johri as A Key Managerial Personnel
New minor risk - Share price stability Apr 23
Investor sentiment deteriorates as stock falls 23% Apr 23
Aster DM Healthcare Limited Declares Special Dividend Apr 13
Aster DM Healthcare Limited Declares Special Dividend Apr 12
Investor sentiment improves as stock rises 19% Apr 08
Aster DM Healthcare Limited Announces Board Changes Apr 03
Olympus Capital Reportedly Plans Stake Sale in Aster DM Healthcare Mar 27
Price target increased by 9.3% to ₹459 Feb 12
New major risk - Financial position Feb 12
Third quarter 2024 earnings: EPS and revenues exceed analyst expectations Feb 09
Aster DM Healthcare Limited to Report Q3, 2024 Results on Feb 08, 2024 Feb 03
Now 20% undervalued Jan 01
KKR, Ontario Teachers' Pension Plan and Care Hospitals Reportedly Submit Non-Binding Term Sheets to Acquire Stake in the Indian Business of Aster DM Healthcare Dec 13
Aster DM Healthcare to Fuel India Expansion Through Buyouts Dec 08
New minor risk - Share price stability Dec 01
Price target increased by 18% to ₹397 Nov 30
Investor sentiment improves as stock rises 17% Nov 29
Second quarter 2024 earnings released: ₹0.62 loss per share (vs ₹0.93 profit in 2Q 2023) Nov 15
Aster's India Unit Reportedly Draws Suitors Valuing Business At $1.5 Billion Oct 12
New major risk - Financial position Aug 17
Aster DM Healthcare Limited Announces Resignation Anoop Moopen as Non-Executive Director Aug 15
Full year 2023 earnings: EPS misses analyst expectations Aug 10
Aster DM Healthcare Limited to Report Q1, 2024 Results on Aug 14, 2023 Aug 08
Aster DM Healthcare Limited, Annual General Meeting, Aug 31, 2023 Aug 04
Aster Healthcare's Promoters Reportedly in Talks with Private Equity Groups, Look to Sell India Business Jul 08
Aster DM Healthcare Confirms Talks with Fajr Capital, Others on Gulf Business Jul 06
Investor sentiment improves as stock rises 16% Jul 04
Price target increased by 7.6% to ₹291 May 29
Aster Eye $300 million India Stake Sale May 27
Full year 2023 earnings released: EPS: ₹8.54 (vs ₹10.58 in FY 2022) May 26
Aster DM Healthcare Limited Announces Resignation of Sridar Arvamudhan Iyengar as Non-Executive Independent Director May 25
Aster DM Healthcare Limited to Report Q4, 2023 Results on May 25, 2023 May 20
Third quarter 2023 earnings released: EPS: ₹2.80 (vs ₹2.98 in 3Q 2022) Feb 15
Aster DM Healthcare Limited Appoints Rahul Kadavakolu as Group Chief Marketing Officer Feb 10
Aster DM Healthcare Limited to Report Q3, 2023 Results on Feb 14, 2023 Feb 09
Aster DM Healthcare Limited Announces Resignation of Sreenath Pocha Reddy as Group Chief Financial Officer, Effective 5 January 2023 Jan 06
Price target increased to ₹275 Nov 16
Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Nov 16
Less than half of directors are independent Nov 16
Aster DM Healthcare Limited Announces Retirement of Prof. Biju Varkkey as Non-Executive Independent Director Nov 12
Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Nov 11
Aster DM Healthcare Limited to Report Q2, 2023 Results on Nov 10, 2022 Nov 05
Aster DM Healthcare Limited (NSEI:ASTERDM) entered into share purchase agreement to acquire 22.69% stake in Sri SaiNatha Multi Speciality Hospitals Pvt. Ltd from promoters and their relatives for INR 250 million. Oct 21
Investor sentiment improved over the past week Sep 08
Aster DM Healthcare Limited to Report Q1, 2023 Results on Aug 11, 2022 Aug 07
Full year 2022 earnings: EPS and revenues exceed analyst expectations Aug 04
Investor sentiment improved over the past week Jul 19
Investor sentiment improved over the past week May 31
Aster DM Healthcare Limited, Annual General Meeting, Aug 25, 2022 May 25
Full year 2022 earnings: EPS and revenues exceed analyst expectations May 25
Aster DM Healthcare Limited to Report Q4, 2022 Results on May 24, 2022 May 17
Less than half of directors are independent Apr 27
Third quarter 2022 earnings: EPS and revenues exceed analyst expectations Feb 09
Aster DM Healthcare Limited to Report Q3, 2022 Results on Feb 08, 2022 Feb 03
Price target increased to ₹232 Nov 30
Second quarter 2022 earnings released: EPS ₹2.15 (vs ₹0.66 in 2Q 2021) Nov 12
Non-Executive Independent Director Suresh Kumar has left the company Sep 19
Price target increased to ₹210 Sep 03
Investor sentiment improved over the past week Sep 01
Investor sentiment improved over the past week Aug 18
Full year 2021 earnings released: EPS ₹2.97 (vs ₹5.51 in FY 2020) Jul 24
Aster DM Healthcare Limited entered into an agreement to acquire a 86% stake in Hindustan Drug House for approximately INR 167 million. Jun 30
Full year 2021 earnings released: EPS ₹2.97 (vs ₹5.51 in FY 2020) Jun 25 Hissedar Getirileri 540975 IN Healthcare IN Pazar 7D 1.4% -1.3% -4.2% 1Y 23.0% 41.8% 19.1%
Hissedar getirilerinin tamamını görün
Getiri vs. Endüstri: 540975 geçen yıl % 41.8 oranında getiri sağlayan Indian Healthcare sektörünün gerisinde kaldı.
Getiri vs Piyasa: 540975 geçen yıl boyunca % 19.1 oranında getiri sağlayan Indian Piyasası ile eşleşti.
Fiyat Oynaklığı Is 540975's price volatile compared to industry and market? 540975 volatility 540975 Average Weekly Movement 5.0% Healthcare Industry Average Movement 5.7% Market Average Movement 6.2% 10% most volatile stocks in IN Market 9.0% 10% least volatile stocks in IN Market 4.1%
İstikrarlı Hisse Senedi Fiyatı: 540975 son 3 ayda önemli bir fiyat oynaklığı yaşamadı.
Zaman İçindeki Volatilite: 540975 'nin haftalık oynaklığı ( 5% ) son bir yıldır istikrarlı seyretti.
Şirket Hakkında Aster DM Healthcare Limited, bağlı ortaklıklarıyla birlikte Hindistan, Birleşik Arap Emirlikleri, Katar, Umman, Suudi Arabistan Krallığı, Ürdün, Kuveyt ve Bahreyn ile Mauritius Cumhuriyeti'nde sağlık ve yardımcı hizmetler sunmaktadır. Hastaneler, Klinikler, Perakende Eczaneler ve Diğer segmentleri aracılığıyla faaliyet göstermektedir. Şirket, hastaneler ve hastanelerdeki kurum içi eczaneler; klinikler ve kliniklerdeki kurum içi eczanelerin yanı sıra perakende ve çevrimiçi eczaneler ve optik satış mağazaları işletmektedir.
Daha fazla göster Aster DM Healthcare Limited Temel Bilgiler Özeti Aster DM Healthcare'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır? 540975 temel i̇stati̇sti̇kler Piyasa değeri ₹242.09b Kazançlar(TTM ) ₹2.26b Gelir(TTM ) ₹40.17b
Kazanç ve Gelir En son kazanç raporundan temel karlılık istatistikleri (TTM) 540975 gelir tablosu (TTM ) Gelir ₹40.17b Gelir Maliyeti ₹17.95b Brüt Kâr ₹22.21b Diğer Giderler ₹19.95b Kazançlar ₹2.26b
Temettüler
0.4% Mevcut Temettü Verimi
Şirket Analizi ve Finansal Veri Durumu Veri Son Güncelleme (UTC saati) Şirket Analizi 2024/12/20 04:40 Gün Sonu Hisse Fiyatı 2024/12/20 00:00 Kazançlar 2024/09/30 Yıllık Kazançlar 2024/03/31
Veri Kaynakları Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC 'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.
Paket Veri Zaman Çerçevesi Örnek ABD Kaynağı * Şirket Finansalları 10 yıl Gelir tablosu Nakit akış tablosu Bilanço Analist Konsensüs Tahminleri +3 yıl Finansal tahminler Analist fiyat hedefleri Piyasa Fiyatları 30 yıl Hisse senedi fiyatları Temettüler, Bölünmeler ve Eylemler Sahiplik 10 yıl En büyük hissedarlar İçeriden öğrenenlerin ticareti Yönetim 10 yıl Liderlik ekibi Yönetim Kurulu Önemli Gelişmeler 10 yıl
* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılır.
Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Buradan daha fazla bilgi edinin.
Analiz Modeli ve Kar Tanesi Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları Github sayfamızda mevcuttur, ayrıca raporlarımızın nasıl kullanılacağına dair kılavuzlarımız ve Youtube' da eğitimlerimiz bulunmaktadır.
Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.
Endüstri ve Sektör Metrikleri Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları 'da mevcuttur.
Analist Kaynakları Aster DM Healthcare Limited 19 Bu analistlerden 9, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.
Analist Kurum Vijayaraghavan Swaminathan Avendus Spark Harith Ahamed Avendus Spark Kunal Randeria Axis Capital Limited
Göster 16 daha fazla analist 
